JENATTE CLARK: Open Payments
NPI 1003250663 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,308 in 42 payments from 8 companies in 2025. Trend: 2023 $199 · 2024 $917 · 2025 $1,308
Food & beverage: $1,109Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $823 |
| Lilly USA, LLC | 4 | $167 |
| ABBVIE INC. | 2 | $150 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $46 |
| GENZYME CORPORATION | 2 | $43 |
| Incyte Corporation | 1 | $26 |
| Janssen Scientific Affairs, LLC | 1 | $1 |
Products named: TREMFYA, BOTOX, EBGLYSS, DUPIXENT, Odomzo, TALTZ, LIBTAYO, OPZELURA.
Industry payments across WA — which companies pay providers there.
